Granulovacuolar degeneration
Granulovacuolar degeneration refers to the occurrence within neurons of abnormal, fluid-filled bubbles (vacuoles) containing a dense proteinaceous granule.[1] Granulovacuoles occur most commonly in pyramidal neurons of the hippocampus, although in some circumstances they can be found in neurons in other parts of the brain.[1] They are present in small numbers in non-demented elderly people, but they increase in frequency in Alzheimer's disease and other tauopathies.[2] In Alzheimer's disease, granulovacuoles proliferate stage-wise in different brain areas, and their prevalence is correlated with the degree of tauopathy, Aβ plaque pathology, and cerebral amyloid angiopathy.[2] Immunohistochemical analyses have found evidence that the inner granule includes proteins such as tubulin[3] tau protein, TDP-43 and several others.[2][4][5] However, the presence of some proteins, including tau, has been questioned because of technical limitations in the immunohistochemical detection of certain protein epitopes.[6]
Although granulovacuoles and their functional significance are incompletely understood, they have been compared to autophagic vacuoles[7] and to proteolytically active lysosomes.[5] In experimental models, granulovacuoles can be generated when tauopathy is induced in cells by exposure to abnormally folded seeds of tau protein.[5] The inclusions also can be found within some neurons in cases of Parkinson's disease, and they are experimentally inducible by exposure of cells to abnormal α-synuclein seeds, suggesting that they are not characteristic only of tauopathies.[8] Studies in cell culture indicate that the formation of granulovacuoles is regulated by casein kinase 1δ, and that they may serve to protect neurons from tauopathy-mediated neurodegeneration.[6]
References
- 1 2 Adams, J. Hume; Corsellis, J.A.N.; Duchen, L.W. (1984). Greenfield's Neuropathology (4th ed.). New York: John Wiley and Sons. pp. 24, 966–967. ISBN 0-471-82307-4.
- 1 2 3 Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJM; Rozemuller AJ; Braak H; Knippschild U (2011). "Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response". Acta Neuropathologica. 122 (5): 577–589. doi:10.1007/s00401-011-0871-6. hdl:1871/34648. PMID 21935637.
- ↑ Price DL; Altschuler RJ; Struble RG; Casanova MF; Cork LC; Murphy DB (1986). "Sequestration of tubulin in neurons in Alzheimer's disease". Brain Research. 385 (2): 305–310. doi:10.1016/0006-8993(86)91077-2. PMID 3096492.
- ↑ Koper MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, Vandenbulcke M, von Arnim CA, Tousseyn T, Balusu S, De Strooper B, Thal DR (2020). "Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer's disease". Acta Neuropathologica. 139 (3): 463–484. doi:10.1007/s00401-019-02103-y. PMID 31802237.
- 1 2 3 Wiersma VI, Hoozemans JJ, Scheper W (2020). "Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies". Acta Neuropathologica Communications. 8 (1) 153. doi:10.1186/s40478-020-00996-5. PMC 7469111. PMID 32883341.
- 1 2 Smits J, Ligthart TW, Jorge-Oliva M, Middelhoff S, Schipper F, Pita-Illobre D, Li KW, Scheper W (2026). "Neurons with granulovacuolar degeneration bodies are resilient to tau-induced protein synthesis impairment". Science Advances. 12 (10) eaea8940. Bibcode:2026SciA...12a8940S. doi:10.1126/sciadv.aea8940. PMC 12965320. PMID 41790889.
- ↑ Köhler C (2016). "Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology". Acta Neuropathologica. 132 (3): 339–359. doi:10.1007/s00401-016-1562-0. PMID 27062260.
- ↑ Jorge-Oliva M, Smits J, Wiersma V, Hoozemans J, Scheper W (2022). "Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology". Alzheimer's Research and Therapy. 14 (1) 187. doi:10.1186/s13195-022-01128-y. PMC 9749177. PMID 36517915.